Previous close | 147.20 |
Open | 147.60 |
Bid | 146.95 x 30000 |
Ask | 147.15 x 30000 |
Day's range | 146.35 - 147.60 |
52-week range | 112.35 - 150.10 |
Volume | |
Avg. volume | 39,049 |
Market cap | 229.95B |
Beta (5Y monthly) | 0.17 |
PE ratio (TTM) | 38.88 |
EPS (TTM) | 3.78 |
Earnings date | 25 Jul 2024 |
Forward dividend & yield | 2.65 (1.80%) |
Ex-dividend date | 22 Feb 2024 |
1y target est | N/A |
Viewing insider transactions for AstraZeneca PLC's ( LON:AZN ) over the last year, we see that insiders were net...
In the most recent trading session, Astrazeneca (AZN) closed at $79.31, indicating a -0.35% shift from the previous trading day.
The FDA approves AstraZeneca's (AZN) Imfinzi in combination with chemotherapy for treating mismatch repair deficient advanced/recurrent endometrial cancer based on data from the phase III DUO-E study.